Short-term and long-term synaptic plasticity are cellular correlates of learning and memory of different durations. Little is known, however, how these two forms of plasticity interact at the same synaptic connection. We examined the reciprocal impact of short-term heterosynaptic or homosynaptic plasticity at sensorimotor synapses of Aplysia in cell culture when expressing persistent long-term facilitation (P-LTF) evoked by serotonin [5-hydroxytryptamine (5-HT)]. Short-term heterosynaptic plasticity induced by 5-HT (facilitation) or the neuropeptide FMRFa (depression) and short-term homosynaptic plasticity induced by tetanus [post-tetanic potentiation (PTP)] or low-frequency stimulation [homosynaptic depression (HSD)] of the sensory neuron were expressed in both control synapses and synapses expressing P-LTF in the absence or presence of protein synthesis inhibitors. All forms of short-term plasticity failed to significantly affect ongoing P-LTF in the absence of protein synthesis inhibitors. However, P-LTF reversed to control levels when either 5-HT or FMRFa was applied in the presence of rapamycin. In contrast, P-LTF was unaffected when either PTP or HSD was evoked in the presence of either rapamycin or anisomycin. These results indicate that synapses expressing persistent plasticity acquire a "new" baseline and functionally express short-term changes as naive synapses, but the new baseline becomes labile following selective activations-heterosynaptic stimuli that evoke opposite forms of plasticity-such that when presented in the presence of protein synthesis inhibitors produce a rapid reversal of the persistent plasticity. Activity-selective induction of a labile state at synapses expressing persistent plasticity may facilitate the development of therapies for reversing inappropriate memories.
Introduction
Long-term memories and their cellular correlates can be disrupted by interventions at various stages from induction to maintenance (McGaugh, 2000; . Persistent memories can be reversed when reactivated (reconsolidation) and paired with a manipulation: inhibitors of protein synthesis, specific kinases, or receptor activation (Nader et al., 2000; Kelly et al., 2003; Duvarci and Nader, 2004; Morris et al., 2006; Tronson et al., 2006; Boccia et al., 2007; Lubin and Sweatt, 2007; Zhang et al., 2010; Inda et al., 2011; Cai et al., 2012; Da Silva et al., 2013; Li et al., 2013) . However, it is generally difficult to determine (1) whether the same synapses encoding the memory are also undergoing reversals in cellular properties to mediate the memory reversal, or (2) the properties of the stimulus at the reactivated synapses that evokes the labile state that underlies the reversal when paired with the manipulation.
In Aplysia, persistent long-term facilitation (P-LTF) of sensorimotor synapses is a cellular correlate of persistent long-term sensitization of defensive withdrawal reflexes, a form of fear memory . Structural and functional changes at identified presynaptic sensory neurons and postsynaptic motor neurons contribute to P-LTF and to long-term sensitization of defensive withdrawal reflexes (Frost et al., 1985; Bailey and Chen, 1988; Glanzman et al., 1990; Trudeau and Castellucci, 1995; Mauelshagen et al., 1996 Mauelshagen et al., , 1998 Zhu et al., 1997; Hatada et al., 2000; Sherff and Carew, 2002; Wainwright et al., 2002; Cai et al., 2008; . The gill-siphon withdrawal behavior and sensorimotor synapses express bidirectional plasticity lasting minutes to weeks that reflect the nature, number, and temporal pattern of the stimuli (Pinsker et al., 1973; Castellucci et al., 1978; Montarolo et al., 1986 Montarolo et al., , 1988 Dale et al., 1988; Bailey et al., 1992; Zhang et al., 1994; Sutton et al., 2002; Sharma et al., 2003; Hu et al., 2011; Liu et al., 2013) . Using this tractable system allows a direct examination of whether P-LTF becomes labile and undergoes reversal following specific forms of reactivation. Cai et al. (2012) and Lee et al. (2012) reported that different forms of reactivation of Aplysia sensory neuron synapses-application of serotonin [5-hydroxytryptamine (5-HT)] or stimula-tion of the sensory neuron-induce a labile state at the synapse such that when paired with protein synthesis inhibitors evoke a reversal in P-LTF. Does any activation of the synapses expressing persistent plasticity induce a labile state that could lead to reversals of persistent plasticity?
We systematically examined how two forms of short-term heterosynaptic plasticity or two forms of short-term homosynaptic plasticity affect sensorimotor synapses expressing P-LTF. Although significant short-term changes in synaptic strength were produced by the different stimuli as at naive synapses, P-LTF was unaffected. P-LTF rapidly reversed when protein synthesis inhibitor was present during and immediately after stimuli producing heterosynaptic plasticity, but not when inhibitor was present during and immediately after stimuli producing homosynaptic plasticity. Thus, the synapses expressing persistent plasticity functionally undergo short-term bidirectional changes when stimulated, and enter a labile state with selective (heterosynaptic) activation of the synapses.
Materials and Methods
Cell culture and electrophysiology. Sensory neurons were isolated from pleural ganglia dissected from adult animals (60 -80 g; Aplysia californica, which are hermaphrodite) and motor neuron L7s were isolated from juvenile abdominal ganglia (2 g) and maintained in coculture for 7-9 d (Hu et al., 2011) . The coculture contained one sensory neuron and one L7. Standard electrophysiological techniques were used to record EPSP amplitudes evoked in L7. L7s were held at Ϫ80 mV, and EPSP amplitudes were recorded before and after various treatments at the indicated time points (Fig. 1) . Each sensory neuron was stimulated with a brief depolarizing pulse to evoke an action potential using an extracellular electrode placed near the cell body of the sensory neuron. Cultures were fed every other day with medium containing 50% filtered hemolymph and 50% L15 medium. Cultures were maintained at 18°C.
Persistent long-term facilitation. Persistent long-term facilitation lasting more than a week was evoked as reported previously (Hu et al., 2011) . After recording the baseline strength of sensorimotor synapses on day 4, some cultures were exposed to 2 consecutive days of 5 applications of 5-HT (2 5-HT; 5 M; Sigma) each lasting 5 min at 20 min intervals (Fig.  1) . Each application of 5-HT was washed out with solution containing 50% seawater and 50% L15 medium. Cultures were fed medium containing 50% filtered hemolymph and 50% L15 medium before placement in the incubator. Control cultures received mock treatments. Synapse strengths were monitored on day 7, day 8, and, in some cases, day 9.
Short-term heterosynaptic and homosynaptic plasticity. After recording EPSP strength on day 7 (48 h after the last 5-HT application to produce persistent LTF or control cultures treated with vehicle), cultures were exposed to either 5 M 5-HT or 1 M FMRFa (Sigma) for 5 min to evoke short-term heterosynaptic plasticity (Fig. 1) . EPSP amplitudes were reexamined on day 8 and in some cases on day 9. In some cultures, EPSPs were recorded 1 min after the start of washout of the neuromodulator to monitor the magnitude of short-term plasticity. In half of these cultures, EPSP amplitudes were also measured on day 8 and in some cases also on day 9. Other cultures were exposed to the protein synthesis inhibitor rapamycin (100 nM; Calbiochem) for 90 min beginning 30 min before the brief application of neuromodulators or control applications. As above, EPSP amplitudes were re-examined on day 8 and in some cases on day 9. In some cultures, EPSP strength was monitored 1 min after the start of washout of the neuromodulators to monitor the magnitude of shortterm plasticity in the presence of rapamycin. In half of these cultures, EPSPs were also re-examined on day 8 and in some cases on day 9.
The same general procedures were followed for short-term homosynaptic plasticity (Fig. 1) . After recording EPSP amplitude on day 7, sensory neurons (control or 2 5-HT treatment) were stimulated to fire a single action potential at 20 s intervals (eight stimuli) to produce homosynaptic depression (HSD). Other sensory neurons (control or 2 5-HT treatment) were stimulated at 20 Hz for 2 s to produce post-tetanic potentiation (PTP). Other cultures were exposed to 100 nM rapamycin or 10 M anisomycin (Calbiochem) for 90 min beginning 30 min before the stimuli evoking HSD, PTP, or controls. EPSP strength was monitored on day 8 and in some cases on day 9. To monitor the extent of PTP, synapse strength in some cultures was monitored 1 min after the tetanus presented either in the absence or presence of rapamycin. In half of these cultures, EPSPs were also re-examined on day 8 and in some cases on day 9.
Quantification and data analysis. All data are expressed as the mean Ϯ SEM produced by the indicated treatments. The EPSP amplitude was measured in millivolts. To measure the extent of persistent LTF, EPSP amplitude on day 4 was normalized as 100%. The changes in EPSP amplitudes were measured by dividing the EPSP amplitudes on days 7-9 by the EPSP amplitude on day 4, multiplied by 100%. No change in amplitude is represented as 100%. To measure the changes evoked by the brief exposure to 5-HT or FMRFa, and homosynaptic plasticity evoked by HSD or PTP, the initial EPSP amplitude on day 7 was normalized as 100%. The change in EPSP amplitude associated with short-term plasticity is expressed by dividing the amplitude of each EPSP by the amplitude of the first EPSP measured on day 7 multiplied by 100%. The brief application of 5-HT to sensorimotor synapses expressing P-LTF typically (ϳ70%) resulted in an increase in synaptic strength that was expressed as an action potential in L7 (Fig. 2A) . A second test was given 20 s later. This EPSP was assumed to be 40% lower, since this is the average decline associated with HSD (Fig. 3A) . Thus, the strength of the synapse with Figure 1 . Experimental timeline to monitor the interactions between short-term synaptic plasticity and persistent LTF. EPSPs were recorded before (day 4 pre-EPSP) and after (days 7 and 8 post-EPSP) 2 5-HT (bottom) or control treatments (top). 5-HT treatments (5 bath applications of 5 M 5-HT each lasting 5 min at 20 min intervals) were given on days 4 and 5, and produces P-LTF. After monitoring the EPSP amplitudes on day 7, cultures (controls or 2 5-HT) received different forms of short-term synaptic activations. Some cultures were exposed to a brief application (5 min) of 5-HT or FMRFa (heterosynaptic plasticity) in the absence or presence of rapamycin, while in other cultures sensory neurons were stimulated (homosynaptic plasticity) by either low-frequency stimulation (8 single action potentials at 20 s intervals) or a tetanus (20 Hz for 2 s) in the absence or presence of rapamycin. To monitor the response of short-term synaptic activation, EPSP amplitudes for some cultures were recorded 1 min after stimuli that produced different forms of short-term synaptic plasticity. On day 8, EPSPs were recorded to monitor the effect of different forms of short-term synaptic plasticity on persistent P-LTF or on control treatment.
short-term facilitation was determined (if an action potential was generated with the first test stimulus) as the amplitude of the second EPSP ϫ 1.4. A two-factor ANOVA (treatment ϫ repeated measure or time) and a onefactor ANOVA (treatment) were used to assess overall significant differences, and the Scheffé's F test was used to gauge significant differences between individual treatments.
Results

Short-term plasticity is coexpressed with persistent long-term facilitation
The sensorimotor synapse expresses P-LTF lasting more than a week (Hu et al., 2011) . We examined whether bidirectional short-term heterosynaptic and homosynaptic plasticity are expressed at 48 h after the last application of 5-HT and whether the synaptic changes evoked by the different stimuli affected the persistence of the plasticity. After recording the EPSP on day 7 in control and 2 5-HTtreated cultures, the synapses were activated by a brief application of 5-HT (heterosynaptic facilitation), FMRFa (heterosynaptic depression), PTP (homosynaptic facilitation), or HSD (homosynaptic depression). In some cultures, short-term plasticity was evoked in the presence of protein synthesis inhibitors (rapamycin or anisomycin). The strengths of synapses were monitored 1 min after the application of either 5-HT or FMRFa, or after tetanus in the presence or absence of rapamycin to measure the extent of short-term plasticity. In half of these cultures EPSPs were also recorded 24 -48 h later to monitor the maintenance of P-LTF. For these cultures, the additional test of synapse strength did not alter the maintenance of P-LTF or its potential reversal when rapamycin was present during the stimuli.
Short-term heterosynaptic plasticity was not affected at sensorimotor synapses expressing P-LTF (Fig. 2) . A brief application of 5-HT evoked comparable increases in EPSP amplitude 1 min later in both naive synapses and synapses expressing P-LTF ( Fig.  2A) . The brief application of 5-HT produced an increase of 178 Ϯ 12.4% at synapses expressing P-LTF (N ϭ 6) that was not significantly different ( p Ͼ 0.9) than the increase of 176 Ϯ 10.2% in controls (N ϭ 6). Similarly, a brief application of FMRFa resulted in a depression of the EPSP amplitude to 60 Ϯ 5.6% (N ϭ 6) at synapses expressing P-LTF that was not significantly different ( p Ͼ 0.6) than the depression in the EPSP amplitude to 65 Ϯ 4.8% (N ϭ 6) in controls (Fig. 2B) . The average overall depression evoked by FMRFa at synapses expressing P-LTF resulted in synapse strength returning to the amplitude recorded on day 4 before the applications of 5-HT that evoked P-LTF (102 Ϯ 5.1%). Thus, short-term heterosynaptic plasticity (bidirectional changes in EPSP amplitude) does not appear to be altered by the expression of P-LTF.
Short-term heterosynaptic plasticity at synapses expressing P-LTF was unaffected by the presence of rapamycin (Fig. 2) . In the presence of rapamycin, a brief application of 5-HT increased EPSP amplitude to 173 Ϯ 9.4% at synapses expressing P-LTF (N ϭ 6), which was not significantly different ( p Ͼ 0.9) than the increase of 178 Ϯ 13.7% evoked by 5-HT at naive synapses in the presence of rapamycin (N ϭ 5; Fig. 2A ). Short-term depression evoked by FMRFa was also unaffected by the presence of rapamycin (Fig. 2B) . A brief exposure to FMRFa depressed EPSP amplitudes to 58 Ϯ 5.9% at synapses expressing P-LTF (N ϭ 6), which was not significantly different ( p Ͼ 0.6) than a decline in amplitude to 64 Ϯ 5.5% at control synapses (N ϭ 6) in the presence of rapamycin (Fig. 2B) . As for changes evoked in the absence of rapamycin, the overall depression evoked by FMRFa at synapses expressing P-LTF resulted in synapse strength returning to the amplitude recorded on day 4 before the applications of 5-HT that evoked P-LTF (103 Ϯ 5.7%). Individual group changes evoked by either 5-HT or FMRFa in the presence of rapamycin were not significantly different ( p Ͼ 0.6 or higher for both controls and those expressing P-LTF) than those evoked in the absence of rapamycin. Thus, protein synthesis is not required for the expression of short-term plasticity at synapses expressing persistent plasticity; post-translational modifications of existing Figure 2 . Persistent LTF did not affect the expression of short-term heterosynaptic plasticity. A, Short-term synaptic facilitation induced by 5-HT was not affected by P-LTF expressed at the same synapses. Left, Sample traces of EPSPs evoked in L7 on day 7 before (Pre) and 1 min after (Post) a 5 min application of 5-HT at control synapses or synapses expressing P-LTF either in the absence or presence of rapamycin (Rapa). Right, Summary of the short-term changes in EPSP amplitudes. A two-factor ANOVA (treatment ϫ repeated measures) indicated no significant effect on the expression of short-term facilitation evoked in each group (df ϭ 3, 19; F ϭ 0.097; p Ͼ 0.9), but a one-factor ANOVA shows a significant facilitation in each group evoked by the brief 5-HT application (F ϭ 436.924, p Ͻ 0.001; see Results). B, Short-term synaptic depression induced by FMRFa was not affected by P-LTF expressed at the same synapses. Left, Sample traces of EPSPs evoked in L7 on day 7 before (Pre) and 1 min after (Post) a 5 min application of FMRFa at control synapses or synapses expressing P-LTF either in the absence or presence of rapamycin. Right, Summary of the short-tern changes in EPSP amplitudes. A two-factor ANOVA indicated no significant effect on the expression of short-term depression with treatment (df ϭ 3, 20; F ϭ 2.494; p Ͼ 0.08), but a one-factor ANOVA shows a significant depression evoked in each group by a brief application of FMRFa (F ϭ 1245.629, p Ͻ 0.001; see Results).
proteins continue to contribute to the expression of short-term plasticity.
Short-term homosynaptic plasticity was not affected when sensorimotor synapses express P-LTF (Fig. 3) . With lowfrequency stimulation, the kinetics of HSD is unaffected when sensorimotor synapses express P-LTF (Fig. 3A) . When normalized to the initial EPSP on day 7 (100%), the decline in EPSP amplitude at synapses express P-LTF (N ϭ 10) with each successive stimulus to the sensory neuron was a close match ( p Ͼ 0.9) to the decline evoked in control synapses (N ϭ 10). The presence of rapamycin did not alter the kinetics of HSD for synapses expressing P-LTF (N ϭ 10) or controls (N ϭ 10). By the last stimulus, EPSP amplitudes declined to 36 Ϯ 2.6% and 37 Ϯ 2.7% at synapses expressing P-LTF in the absence or presence of rapamycin, and declined to 38 Ϯ 4.3% and 39 Ϯ 3.9% at control synapses in the absence or presence of rapamycin (Fig.  3A) . For synapses expressing P-LTF, the overall decline after the last stimulus was to 61 Ϯ 3.6% (absence of rapamycin) and 59 Ϯ 5.9% (presence of rapamycin) of the EPSP amplitude recorded on day 4 before the applications of 5-HT that evoked P-LTF. Thus, the expression of HSD is unaffected at synapses expressing P-LTF and, as at naive synapses, does not depend on protein synthesis.
Short-term homosynaptic facilitation was not affected by P-LTF in the absence or presence of rapamycin (Fig. 3B) . Tetanic stimulation of the sensory neuron evoked an increase in EPSP amplitude of 135 Ϯ 10.6% (N ϭ 6) at sensorimotor synapses expressing P-LTF that was not significantly different ( p Ͼ 0.8) than the increase of 140 Ϯ 10.5% (N ϭ 6) at control synapses. In the presence of rapamycin, titanic stimulation evoked comparable increases in EPSP amplitude: 134 Ϯ 8.9% at synapses expressing P-LTF (N ϭ 7) compared with 138 Ϯ 9.4% at control synapses (N ϭ 7). Thus, short-term homosynaptic plasticity (bidirectional changes in EPSP amplitude) does not appear to be altered by the expression of P-LTF. Short-term homosynaptic plasticity is independent of ongoing protein synthesis that may contribute to the persistent plasticity, but is dependent on any activity-dependent post-translational modifications of existing proteins.
Heterosynaptic, but not homosynaptic, activation in the presence of rapamycin rapidly reverses P-LTF Short-term heterosynaptic or homosynaptic activation of sensorimotor synapses expressing P-LTF did not interfere with P-LTF (Figs. 4, 5 ). EPSPs were recorded on day 8 (and in some cases on day 9; data not shown), maintained a significant increase over controls, and were not significantly different from sensorimotor synapses expressing P-LTF that were not stimulated to express short-term plasticity on day 7.
Following short-term facilitation evoked by a brief application of 5-HT (Fig. 4A) , synapse strength on day 8 remained significantly elevated at synapses expressing P-LTF: 171 Ϯ 6.3% (N ϭ 10) in cultures exposed to 5-HT on day 7 (2 5-HT plus 5-HT) compared with 168 Ϯ 7.4% in cultures treated with 2 5-HT alone (N ϭ 10) or 166 Ϯ 10.6% in cultures treated with 2 5-HT plus vehicle on day 7 (N ϭ 6). Control cultures exposed to a single brief application of 5-HT or vehicle on day 7 failed to show any significant change in EPSP amplitude on day 8: 96 Ϯ 3.6% (N ϭ 6) or 96 Ϯ 3.3% (N ϭ 6) compared with control (95 Ϯ 4.1%; N ϭ 10). Following short-term depression evoked by a brief application of FMRFa (Fig. 4B) , synapse strength on day 8 also remained significantly elevated at synapses expressing P-LTF: 170 Ϯ 11.5% (N ϭ 12) in cultures exposed to FMRFa on day 7 (2 5-HT plus FMRFa) compared with 170 Ϯ 13.0% (N ϭ 10) in cultures treated with 2 5-HT alone or 167 Ϯ 10.4% in cultures treated with 2 5-HT plus vehicle on day 7 (N ϭ 6). Control cultures exposed to a single brief application of FMRFa or vehicle on day 7 failed to show a significant change in EPSP amplitude on day 8: 95 Ϯ 3.6% (N ϭ 6) or 96 Ϯ 3.3% (N ϭ 6) compared with control (94 Ϯ 6.3%; N ϭ 10). Thus, stimuli that evoke short-term heterosynaptic plasticity do not alter P-LTF.
Stimuli that evoked short-term homosynaptic plasticity also did not alter P-LTF (Fig. 5) . Following HSD evoked by lowfrequency stimulation or PTP evoked by tetanus, synapse strength on day 8 remained significantly elevated at synapses expressing P-LTF: 164 Ϯ 8.2% (N ϭ 10) following HSD evoked on day 7 (2 5-HT plus HSD), 168 Ϯ 7.9% (N ϭ 10) following PTP evoked on day 7 (2 5-HT plus PTP) compared with 173 Ϯ 9.8 (2 5-HT; N ϭ 13) at synapses receiving no stimuli on day 7 (Fig. 5) . . Persistent LTF did not affect the expression of short-term homosynaptic plasticity. A, Kinetics of HSD on day 7 in the absence or presence of rapamycin is not altered at the same synapses expressing persistent LTF. The first EPSP amplitude for all treatments was normalized as 100%. By the eighth stimulus, EPSP amplitudes were depressed to ϳ38% for all conditions. A two-factor ANOVA indicated no significant effect on the kinetics of HSD for each group (df ϭ 18, 216; F ϭ 0.520; p Ͼ 0.9), but a one-factor ANOVA shows a significant decline in EPSP amplitude for all treatments (F ϭ 236.888, p Ͻ 0.001). B, PTP was not affected by P-LTF expressed at the same synapses. Left, Sample traces of EPSPs evoked in L7 on day 7 before (Pre) and 1 min after (Post) tetanic stimulation in the absence or presence or rapamycin. A two-factor ANOVA indicated no significant effect on the expression of PTP for each group (df ϭ 3, 22; F ϭ 0.203; p Ͼ 0.8), but a one-factor ANOVA shows a significant increase in EPSP amplitude for each treatment (F ϭ 144.274; p Ͻ 0.001).
HSD or PTP stimulation of control cultures on day 7 did not significantly affect synapse strength on day 8: 95 Ϯ 3.4% (N ϭ 6) or 94 Ϯ 4.4% (N ϭ 6) compared with control (94 Ϯ 3.1%; N ϭ 10). Thus, exposure to short-term plasticity, even those that depress synapses to levels at or below the initial basal level of synapse strength, failed to alter P-LTF. The elevated synapse strength associated with P-LTF appears as a "new" baseline where synapse strength can be modulated up or down for short durations as in control naive synapses.
Short-term heterosynaptic activation of the sensorimotor synapses in the presence of rapamycin evoked a rapid reversal to basal levels at sensorimotor synapses expressing P-LTF (Fig. 4) . Brief application of 5-HT on day 7 in the presence of rapamycin [2 5-HT plus (rapamycin plus 5-HT); N ϭ 11] resulted in the failure to maintain P-LTF on day 8 (and day 9; data not shown).
EPSP amplitude was now comparable to controls (N ϭ 10): 105 Ϯ 7.1% compared with 95 Ϯ 4.1%, respectively (Fig. 4A) . Similarly, a brief application of FMRFa on day 7 in the presence of rapamycin [2 5-HT plus (rapamycin plus FMRFa); N ϭ 12] also resulted in the failure to maintain P-LTF on day 8 (and day 9; data not shown). EPSP amplitude was now comparable to controls (N ϭ 10): 104 Ϯ 7.0% compared with 94 Ϯ 6.3%, respectively (Fig. 4B) . Application of rapamycin alone (2 5-HT plus rapamycin; N ϭ 11) failed to alter P-LTF (170 Ϯ 5.5% on day 8 compared with 168 Ϯ 7.4% on day 8 for 2 5-HT alone, N ϭ 10; Fig. 4A ). In addition, evoking short-term heterosynaptic plasticity in the presence of rapamycin in control "naïve" sensorimotor synapses failed to alter synapse strength on day 8 [94 Ϯ 3.1% in control cultures treated with a brief of 5-HT (N ϭ 6) compared with 95 Ϯ 4.1% in control alone; 95 Ϯ 4.0% in control cultures treated with . Persistent LTF was disrupted by short-term heterosynaptic plasticity only in the presence of rapamycin. A, Persistent LTF is reversed when short-term heterosynaptic plasticity is evoked by 5-HT in the presence of rapamycin. Left, Traces of EPSPs evoked in L7 for different treatments on day 4 (baseline strength of synapses), day 7 (strength after control or 2 5-HT treatments and before brief application of 5-HT in the absence or presence of rapamycin, or an application of rapamycin alone), and day 8 (strength after all day 7 treatments). Right, Summary of the changes in EPSP amplitudes over time for each condition. A two-factor ANOVA indicated a significant effect of treatments on the changes in EPSP over time (df ϭ 8, 94; F ϭ 81.957; p Ͻ 0.001). Individual group comparisons indicated a significant increase in EPSP amplitude over control on day 7 for all groups treated with 2 5-HT (F values between 11.068 and 12.380; p Ͻ 0.01). On day 8, all groups treated with 2 5-HT remained significantly higher than controls (F values between 16.668 and 18.340; p Ͻ 0.01) except for the group treated with a brief application of 5-HT in the presence of rapamycin on day 7 [2 5-HT plus (rapamycin plus 5-HT)], which resulted in a change in EPSP amplitude that was no longer significantly different from controls (F ϭ 0.351; p Ͼ 0.05), but was significantly lower than those of 2 5-HT, 2 5-HT plus 5-HT, and 2 5-HT plus rapamycin (F values between 12.860 and 14.296; p Ͻ 0.01). B, Persistent LTF is reversed when short-term heterosynaptic plasticity is evoked by FMRFa in the presence of rapamycin. Left, Sample traces of EPSPs evoked in L7 for different treatments on day 4 (baseline strength of synapses), day 7 (strength after control or 2 5-HT treatments and before a brief application of FMRFa in the absence or presence of rapamycin), and day 8 (strength after all day 7 treatments). Right, Summary of the changes in EPSP amplitudes over time for each condition. A two-factor ANOVA indicated a significant effect of treatments on the changes in EPSP over time (df ϭ 6, 80; F ϭ 50.906; p Ͻ 0.001). Individual group comparisons indicated a significant increase in EPSP amplitude over control on day 7 for all groups treated with 2 5-HT (F values between 7.889 and 8.393; p Ͻ 0.01). On day 8, all groups treated with 2 5-HT remained significantly higher than control (F values between 9.000 and 9.667; p Ͻ 0.01) except for the group treated with a brief application of FMRFa in the presence of rapamycin on day 7 [2 5-HT plus (rapamycin plus FMRFa)], which resulted in a change in EPSP amplitude that was no longer significantly different from control (F ϭ 0.174; p Ͼ 0.05), but was significantly lower than those of 2 5-HT and 2 5-HT plus FMRFa (F ϭ 7.378 and 7.981; p Ͻ 0.01).
a brief application of FMRFa (N ϭ 6) compared with 94 Ϯ 6.3% in control alone]. Thus, heterosynaptic activation of sensorimotor synapses (evoking bidirectional changes in synapse strength) expressing persistent plasticity results in a labile state where the presence of a protein synthesis inhibitor leads to a rapid reversal in persistent long-term plasticity.
Homosynaptic activation of the sensorimotor synapses in the presence of rapamycin failed to evoke a significant change in synapse strength at sensorimotor synapses expressing P-LTF (Fig. 5) . HSD (N ϭ 11) or PTP (N ϭ 13) evoked on day 7 in the presence of rapamycin did not significantly affect the enhanced EPSP amplitudes on day 8 at synapses expressing P-LTF: 169 Ϯ 9.5% after HSD [2 5-HT plus (rapamycin plus HSD)] and 165 Ϯ 7.5% after PTP [2 5-HT plus (rapamycin plus PTP)]. The P-LTF expressed at these synapses was not significantly different from the P-LTF expressed at synapses exposed to HSD (164 Ϯ 8.2%; N ϭ 10) or PTP (168 Ϯ 7.9%; N ϭ 10) on day 7 in the absence of rapamycin or the P-LTF expressed when no activity was presented on day 7 (173 Ϯ 9.8%; N ϭ 13). We also found that homosynaptic activation in the presence of anisomycin, a general inhibitor of protein synthesis, also failed to reverse P-LTF. Following HSD or PTP on day 7, EPSP amplitudes remained significantly elevated on day 8: 163 Ϯ 11.6% (N ϭ 8) for PTP and 167 Ϯ 8.4% for HSD (N ϭ 9) compared with 95 Ϯ 3.3% for controls (N ϭ 7) . Thus, for a nonassociative form of P-LTF (evoked by repeated applications of 5-HT presented over 2 d), homosynaptic activation of the synapse failed to evoke a labile state in synapses expressing persistent plasticity when the homosynaptic stimuli are presented in the presence of protein synthesis inhibitors.
Discussion
Aplysia sensorimotor synapses can express both nonassociative P-LTF and different forms of short-term plasticity (STP) that are functionally indistinguishable from STP evoked at naive synapses. Even short-term depression that reduced synapse strength to levels at or below levels detected before the initial stimuli did not disrupt P-LTF. Thus, the synapse strength associated with persistent plasticity appears to represent a new baseline that can be modulated bidirectionally to allow the neural circuit to respond appropriately to subsequent stimuli.
However, this new baseline differs from the control baseline in that the "added" strength of the synapse becomes labile when selective forms of neuron-synapse stimulation-heterosynaptic plasticity-are paired with rapamycin. Reconsolidation of stored memories and synaptic plasticity are sensitive to disruption by the timely presence of rapamycin or other inhibitors (Nader et al., 2000; Doyère et al., 2007; Gafford et al., 2011; Stoica et al., 2011; Jobim et al., 2012; Barak et al., 2013; Li et al., 2013) . Generally, the labile nature is expressed in appropriate CNS regions and circuits that participated in the initial learning and with specific external stimuli that reactivate the initial memory. However, these studies could not determine whether the same synapses encoding the initial memory trace are also undergoing reversals in their cellular properties, and the types of stimuli at the reactivated synapses that evoke the labile state. Our results indicate that the labile state in sensorimotor synapses expressing added strength is evoked selectively with modulatory heterosynaptic stimuli including one that evokes plasticity in the opposite direction. Thus, sensorimotor synapses expressing nonassociative P-LTF Figure 5 . Persistent LTF was not disrupted by homosynaptic plasticity either in the absence or presence of rapamycin. Left, Sample traces of EPSPs evoked in L7 for different treatments on day 4 (baseline strength of synapses), day 7 (strength after control or 2 5-HT treatments and before HSD or PTP in the absence or presence of rapamycin), and day 8 (strength after all day 7 treatments). HSD or PTP evoked in the absence or presence of rapamycin did not affect P-LTF produced by 2 5-HT. Right, Summary of the changes in EPSP amplitudes over time for each condition. A two-factor ANOVA indicated a significant effect of treatments on changes in EPSP amplitude over time (df ϭ 10, 122; F ϭ 25.867; p Ͻ 0.001). Individual group comparisons indicated a significant increase in EPSP amplitude over controls on day 7 for all groups treated with 2 5-HT (values of F between 5.993 and 8.365; p Ͻ 0.01), and on day 8 for all groups treated with 2 5-HT (F values between 6.509 and 9.215; p Ͻ 0.01) including those treated with homosynaptic stimulation plus rapamycin on day 7.
are made labile selectively when neuromodulator-induced plasticity is paired with the timely interference of protein synthesis and reverses P-LTF.
Short-term and persistent synaptic plasticity are coexpressed Both homosynaptic and heterosynaptic STP are expressed at synapses expressing P-LTF without any apparent attenuation. Since the stimuli inducing STP activate different cellular/molecular mechanisms, our results suggest that synapses expressing P-LTF retain the same molecular machinery as naive synapses in expressing short-term, activity-dependent plasticity.
Changes in both the number (Bailey and Chen, 1988; Glanzman et al., 1990; Bailey et al., 1992; O'Leary et al., 1995) and function (Frost et al., 1985; Hu et al., 2011; Liu et al., 2013) of sensorimotor synapses contribute to P-LTF. The functional changes include a reduction in silent synapses and an increase in miniature EPSP (mEPSP) frequency Jin et al., 2012) . HSD is primarily produced by a reduction in release probability and a disruption of excitation-secretion coupling at presynaptic varicosities, resulting in the silencing of release sites with low release probability (Eliot et al., 1994; Armitage and Siegelbaum, 1998; Royer et al., 2000; Gover et al., 2002; Zhao and Klein, 2002; Malkinson and Spira, 2013) . Thus, it was somewhat surprising that the kinetics of HSD was unaffected at synapses expressing P-LTF, where release probability and mEPSP frequency are high. The overall properties of release sites at sensorimotor synapses expressing P-LTF are similar to those of naive synapses. This is consistent with the findings that the kinetics of HSD is independent of the initial strength of sensorimotor synapse (Montarolo et al., 1986; Sun and Schacher, 1996) . The cellular/molecular mechanisms for maintaining nonassociative P-LTF do not disrupt the cellular/molecular changes mediating HSD.
The tetanus that evokes PTP at sensorimotor synapses of Aplysia activates both presynaptic and postsynaptic mechanisms: the release of calcium from internal stores, the activation of CaMK and MAPK, and calcium-dependent protein degradation (Schaffhausen et al., 2001; Jin and Hawkins, 2003; Khoutorsky and Spira, 2009) . The activation of MAPK also contributes to LTF at sensorimotor synapses and may contribute to P-LTF Purcell et al., 2003; Hu et al., 2004 Hu et al., , 2011 . In addition, activity-dependent potentiation is typically attenuated at synapses recently potentiated by previous stimuli (Montgomery and Madison, 2004) . Thus, it was surprising that PTP at synapses expressing P-LTF was evoked without apparent attenuation. However, previous studies generally examined the consequences of additional stimuli soon after the induction of activitydependent long-term plasticity. The plasticity induced by the prior stimulation may not have reached the "maintenance" phase of persistent plasticity. Our results suggest that synapses maintaining P-LTF can undergo additional potentiation that is functionally equivalent to PTP expressed at naive synapses.
Synapses expressing P-LTF also express heterosynaptic STP that is functionally equivalent to that expressed at naive synapses. A brief application of 5-HT leads to the activation of kinases in sensory neurons (PKA and PKC) that phosphorylate pre-existing substrates leading to changes in action potential shape and the upregulation of vesicle mobilization (Brunelli et al., 1976; Castellucci et al., 1980; Hochner et al., 1986; Ocorr et al., 1986; Sacktor et al., 1988; Ghirardi et al., 1992; Sugita et al., 1992; Klein, 1993; Byrne and Kandel, 1996) . 5-HT also activates responses and signaling pathways in the postsynaptic motor neuron (Cleary et al., 1998; Li et al., 2005; Villareal et al., 2007; Fulton et al., 2008) . In contrast, FMRFa evokes synaptic depression by activating p38 MAPK and phosphatases that lead to posttranslational modifications in pre-existing substrates that produce spike narrowing and a decline in release probabilities from the sensory neuron release sites (Belardetti et al., 1987; Piomelli et al., 1987; Sweatt et al., 1989; Dale and Kandel, 1990; Pieroni and Byrne, 1992; Small et al., 1992; Endo et al., 1995; Guan et al., 2003) . FMRFa evokes responses in the motor neuron (Ruben et al., 1986; Sossin et al., 1987; Pieroni and Byrne, 1992; Belkin and Abrams, 1993; Wu and Schacher, 1994; Xu et al., 1994; Lin and Glanzman, 1996) , suggesting that FMRFa activates signaling pathways in the postsynaptic neuron. Our results suggest that similar post-translational modifications are evoked by the stimuli at the sensorimotor synapse expressing nonassociative P-LTF as at naive synapses.
Heterosynaptic plasticity selectively evokes a labile state at synapses expressing P-LTF Do 5-HT and FMRFa activate the same signaling cascades in the sensory neuron and L7 when the synapses express P-LTF? Even if the same pathways are activated, do heterosynaptic stimuli lead to modifications of the same substrates in neurons expressing P-LTF as the substrates modified in naive synapses? Molecular changes in the circuit evoked by stimuli that produce persistent plasticity are likely to provide a different group of potential substrates for modification by subsequent heterosynaptic stimuli (Hu et al., 2011) . Persistent plasticity requires persistent changes in proteins levels Si et al., 2010; Pavlopoulos et al., 2011) , in the activation of kinases (Sacktor, 2011; Lisman et al., 2012) , in the expression/activation of transcription factors (Barco et al., 2002 (Barco et al., , 2005 Liu et al., , 2011 , and in epigenetic changes affecting chromatin organization and activation of gene expression (Rajasethupathy et al., 2009 (Rajasethupathy et al., , 2012 Feng et al., 2010) , thereby altering overall levels of mRNA and protein expression. Thus, new levels of expression of pre-existing substrates and of novel substrates associated with P-LTF could be subject to posttranslational modifications when 5-HT or FMRFa evoke STP. Despite these potential differences, P-LTF and STP were unaffected when the two forms of plasticity interacted with each other.
The labile nature of some stimuli, heterosynaptic but not homosynaptic, were revealed when the stimuli were presented in the presence of a protein synthesis inhibitor such as rapamycin. Rapamycin alone failed to induce a labile state and interfere with P-LTF (Hu et al., 2011; Fig. 4) . Lee et al. (2012) reported that the action potential activity of sensory neurons in the presence of a protein synthesis inhibitor also induced a labile state at sensorimotor synapses. The apparent discrepancy with our results may be accounted for by differences in protocol. First, they induced LTF with 1 d of 5-HT applications at concentrations much higher than used here. Second, they used a stimulation protocol of firing a single action potential in sensory neurons at 1 min intervals (4ϫ) that does not evoke any significant plasticity. Third, they stimulated 24 h after termination of the 5-HT applications, which is during the consolidation phase of LTF Liu et al., 2011) . Fourth, they used a powerful protein synthesis inhibitor (100 M emetine) that is only partially reversible. When neurons and synapses express a more consolidated form of P-LTF, they shed the increase in synaptic strength and return to levels of synaptic strength expressed before 5-HT stimulation only when heterosynaptic stimuli are presented in the presence of rapamycin, while naive synapses treated the same way retain their initial baseline levels of synaptic strength.
What is the nature of the labile state when heterosynaptic stimuli are paired with rapamycin? One possibility is that these stimuli selectively lead to the phosphorylation or dephosphorylation of specific proteins in sensory neurons and/or motor neurons that participate in the maintenance of the plasticity. These post-translational changes might lead to added degradation of the modified proteins or of other proteins associated with maintaining P-LTF, which cannot be replenished in a timely manner when protein synthesis is inhibited by rapamycin. The ubiquitinproteasome pathways contribute significantly to long-term plasticity and reconsolidation (Chain et al., 1999b; Karpova et al., 2006; Dong et al., 2008; Lee et al., 2008; Citri et al., 2009; Kaang and Choi, 2011; Da Silva et al., 2013) . Stimuli that evoke long-term plasticity in Aplysia activate this degradation pathway, which may persist long after the induction of the synaptic changes (Chain et al., 1995 (Chain et al., , 1999a Hegde et al., 1997; Lee et al., 2012) . Brief exposure to 5-HT or FMRFa, but not to stimuli that evoke HSD or PTP, may induce a reactivation of this pathway when the neurons express P-LTF (Zhao et al., 2003; Upadhya et al., 2006; Lee et al., 2012) . The identity of the key substrates in sensory and/or motor neurons influenced selectively by both the neuromodulators and rapamycin and the role of protein degradation that may contribute to the labile state and reversal of P-LTF await further study.
